Growing data for recycling tenofovir and lamivudine with dolutegravir as empiric second-line antiretroviral therapy in resource-limited settings

被引：1
|
作者：
Marukutira, Tafireyi [1 ,2 ]
Wood, Brian R. [3 ]
机构：
[1] Monash Univ, Publ Hlth, Burnet Inst, Melbourne, Vic, Australia
[2] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia
[3] Univ Washington, Div Allergy & Infect Dis, Seattle, WA 98195 USA
来源：
AIDS | 2021年 / 35卷 / 09期
关键词：
antiretroviral therapy; HIV; reverse transcriptase inhibitors; REVERSE-TRANSCRIPTASE INHIBITORS; LOPINAVIR PLUS RALTEGRAVIR; ADULTS; NUCLEOSIDE; RESISTANCE; MUTATIONS; K65R;
D O I：
10.1097/QAD.0000000000002958
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：1505 / 1507
页数：3
相关论文
共 50 条
  • [1] Second-line antiretroviral therapy in resource-limited settings:: the experience of Medecins Sans Frontieres
    Pujades-Rodriguez, Mar
    O'Brien, Daniel
    Humblet, Pierre
    Calmy, Alexandra
    AIDS, 2008, 22 (11) : 1305 - 1312
  • [2] Second-line combination antiretroviral therapy in resource-limited settings: facing the challenges through clinical research
    Boyd, Mark A.
    Cooper, David A.
    AIDS, 2007, 21 : S55 - S63
  • [3] Raltegravir in second-line ART in resource-limited settings
    Haas, Andreas D.
    Keiser, Olivia
    LANCET HIV, 2016, 3 (06): : E240 - E241
  • [4] Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring
    Keiser, Olivia
    Tweya, Hannock
    Boulle, Andrew
    Braitstein, Paula
    Schechter, Mauro
    Brinkhof, Martin W. G.
    Dabis, Francois
    Tuboi, Suely
    Sprinz, Eduardo
    Pujades-Rodriguez, Mar
    Calmy, Alexandra
    Kumarasamy, Nagalingeswaran
    Nash, Denis
    Jahn, Andreas
    MacPhail, Patrick
    Luethy, Ruedi
    Wood, Robin
    Egger, Matthias
    AIDS, 2009, 23 (14) : 1867 - 1874
  • [5] Emergence of HIV Drug Resistance During First- and Second-Line Antiretroviral Therapy in Resource-Limited Settings
    Hosseinipour, Mina C.
    Gupta, Ravindra K.
    Van Zyl, Gert
    Eron, Joseph J.
    Nachega, Jean B.
    JOURNAL OF INFECTIOUS DISEASES, 2013, 207 : S49 - S56
  • [6] Dolutegravir for second-line antiretroviral therapy
    Hamers, Raph L.
    LANCET INFECTIOUS DISEASES, 2019, 19 (03): : 218 - 219
  • [7] Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimen
    Keene, Claire M.
    Griesel, Rulan
    Zhao, Ying
    Gcwabe, Zimasa
    Sayed, Kaneez
    Hill, Andrew
    Cassidy, Tali
    Ngwenya, Olina
    Jackson, Amanda
    van Zyl, Gert
    Schutz, Charlotte
    Goliath, Rene
    Flowers, Tracy
    Goemaere, Eric
    Wiesner, Lubbe
    Simmons, Bryony
    Maartens, Gary
    Meintjes, Graeme
    AIDS, 2021, 35 (09) : 1423 - 1432
  • [8] Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis
    Ajose, Olawale
    Mookerjee, Siddharth
    Mills, Edward J.
    Boulle, Andrew
    Ford, Nathan
    AIDS, 2012, 26 (08) : 929 - 938
  • [9] Second-Line Antiretroviral Therapy for HIV-Infected Children in Resource Limited Settings
    Aurpibul, Linda
    Puthanakit, Thanyawee
    CURRENT PEDIATRIC REVIEWS, 2011, 7 (03) : 180 - 187
  • [10] Improving first-line antiretroviral therapy in resource-limited settings
    Ford, Nathan
    Calmy, Alexandra
    CURRENT OPINION IN HIV AND AIDS, 2010, 5 (01) : 38 - 47
12345